CTRA vs KROS · P/E 15, rev $7.64B vs rev $32.0K
Coterra Energy Inc (CTRA) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported CTRA revenue for 2025-12-31 was $7.64B. Net income was $1.72B. Revenue was up 40.1% from 2024-12-31 to 2025-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. KROS currently screens at market cap $208.8M.
Not investment advice. Open the CTRA and KROS stock pages for the full models.
Not investment advice.